PDK1 and prostate carcinoma: Western blotting experiments also showed that the protein levels of Akt1, phospho-Akt Ser473, phospho-Akt Thr308, PDK1, c-Myc, Skp2 in prostate cancer cells was decreased by triol treatment (Fig. 8).